Pediatr. pro Praxi, 2005; 1: 38-41

Epileptický záchvat jako první projev kavernomu mozku

prof. MUDr. Vladimír Mihál CSc1, MUDr. Marta Neklanová1, MUDr. Marie Šimková2, MUDr. David Horák Ph.D3, MUDr. Kamila Michálková4, MUDr. Miroslav Vaverka CSc5, MUDr. Petr Dvořák5, MUDr. Ladislava Kučerová6, MUDr. Bohumila Kropáčková7
1 Dětská klinika LF UP a FN Olomouc
2 Klinika nemocí kožních a pohlavních, LF UK a FN v Hradci Králové
3 Radiologická klinika LF UP a FN, Olomouc
4 Radiologická klinika LF UP a FN Olomouc
5 Neurochirurgická klinika LF UP a FN Olomouc
6 Ústav patologie FN a LF UP Olomouc
7 Dětské oddělení Nemocnice Šternberk

Kavernomy mozku v dětském věku jsou stále diagnosticky i terapeuticky náročné léze. Jejich nejčastějším prvním klinickým projevem je epileptický záchvat (79 %) a/nebo krvácení do mozku (16 %). V éře magnetické rezonance představují kavernomy mnohem častěji diagnostikovanou cévní malformaci. MRI se dnes používá ke klasifikaci, ale i k určení léčebné strategie. Autoři předkládají kazuistiku 13letého pacienta s kavernomem mozku, který se klinicky prezentoval generalizovaným epileptickým záchvatem.

Published: January 1, 2006  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Mihál V, Neklanová M, Šimková M, Horák D, Michálková K, Vaverka M, et al.. Epileptický záchvat jako první projev kavernomu mozku. Pediatr. praxi. 2005;6(1):38-41.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Mottolese C, Hermier M, Stan H, et al. Central nervous system cavernomas in the pediatric age group. Neurosurg Rev 2001; 24: 55-71. Go to original source... Go to PubMed...
    2. Kozler P, Beneš V. Supratentoriální kavernomy. Čes Slov Neurol Neurochir 1999; 62/95: 271-276.
    3. Heckl S, Aschoff A, Kunze S. Radiation-induced cavernous hemangiomas of the brain. A late effect predominantly in children. Cancer 2002; 94: 3285-3291. Go to original source... Go to PubMed...
    4. Moran NF, Fish DR, Kitchen N, et al. Supratentorial cavernous hemangiomas and epilepsy: a review of the literature and case series. J Neurol Neurosurg Psychiatry 1999; 66: 561-568. Go to original source... Go to PubMed...
    5. DenierC, Labauge P, Brunereau L, et al. Clinical features of cerebral cavernous malformations patiens with KRIT1 mutations. Ann Neurol 2004; 55: 213-220. Go to original source... Go to PubMed...
    6. Wang CC, Liu A, Zhang JT, et al. Surgical management of brain-stem cavernous malformations: report of 137 cases. Surg Neurol 2003; 59: 444-454. Go to original source... Go to PubMed...
    7. Wurm G, Kellner FA. Implementation of T2*-weighted MR for multimodal image guidance in cerebral cavernomas. NeuroImage 2004; 22: 841-846. Go to original source... Go to PubMed...
    8. Di Rocco C, Iannelli A, Tamburrini G. Cavernomas of the central nervous system in children. A report of 22 cases. Acta Neurochir (Sien) 1996; 138: 1267-1274. Go to original source... Go to PubMed...
    9. Labauge P, Brunereau L, Lévy C, et al. The natural history of familial cerebral cavernomas: a retrospective MRI study of 40 patients. Neuroradiology 2000; 42: 327-332. Go to original source... Go to PubMed...
    10. Edwards MSB, Baumgartner JE, Wilson CB. Cavernous and other cryptic vascular malformations in the pediatric age group. In: Awad IA, Barrow DL (eds) Cavernous malformations. AANS Publications Committee, Park Ridge 1993; 163-183, 185-186.
    11. Mazza C, Scienza R, Beltramello A, et al. Cerebral cavernous malformations (cavernomas) in the pediatric age group. Child Nerv Syst 1991; 7: 139-146. Go to original source... Go to PubMed...
    12. Berger T, Brandt M, Szüwart U. Cavernous hemangiomas in children. Childs Nerv Syst 1988; 4: 123-127. Go to original source... Go to PubMed...

    Return to the content


    Pediatrics for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.